Nureca Ltd.
Snapshot View

920.05 +16.40 ▲1.8%

07 October 2022, 04:01:00 PM
Volume: 5,531

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.nureca.com
Market Cap 916.87 Cr.
Enterprise Value(EV) 817.79 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 4.63 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 198.50 Trailing Twelve Months Ending 2022-06
Industry PE 66.55 Trailing Twelve Months Ending 2022-06
Book Value / Share 199.07 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.62 Calculated using Price: 920.05
Dividend Yield 0.33 Period Ending 2022-03
No. of Shares Subscribed 1.00 Cr. 10,000,175 Shares
FaceValue 10
Company Profile
Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.81%
1 Week
+3.58%
1 Month
-6.92%
3 Month
-8.57%
6 Month
-35.11%
1 Year
-53.74%
2 Year
5 Year
10 Year
5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 426.30 162.03 61.23 52.39 24.55
Return on Capital Employed (%) 255.06 179.97 56.70 67.61 33.48
Return on Assets (%) 44.35 40.78 22.30 41.38 20.33

Balance Sheet View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 2 8 15 163 203
Non Curr. Liab. 0 0 9 3 4
Curr. Liab. 5 15 10 24 45
Minority Int.
Equity & Liab. 7 24 34 190 252
Non Curr. Assets 0 1 1 4 13
Curr. Assets 7 23 33 186 239
Misc. Exp. not W/O
Total Assets 7 24 34 190 252

Profit Loss View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 20 62 99 213 256 162
Other Income 0 0 0 3 8 7
Total Income 20 62 99 216 263 168
Total Expenditure -16 -53 -90 -152 -200 -159
PBIDT 4 9 10 64 63 9
Interest 0 0 -1 -2 -1 -1
Depreciation 0 0 0 0 -1 -2
Taxation -1 -3 -2 -16 -16 -2
Exceptional Items
PAT 3 6 6 46 45 5
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 3 6 6 46 45 5
Adjusted EPS 445 889 914 46 45 5

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -8 35 1
Cash Fr. Inv. 0 0 0 -110 -3
Cash Fr. Finan. 0 0 8 92 -7
Net Change 0 0 0 17 -9
Cash & Cash Eqvt 0 0 0 17 8

Shareholding Pattern View Details >>

6 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 70.00 70.00 70.00 70.00 70.00 70.00
Public 30.00 30.00 30.00 30.00 30.00 30.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 30 Sep 2022
Closure of Trading Window
Reference to our letter dated September 29 2022 wherein we have informed that the trading window for dealing inequity shares of the Company will be closed from September 30 2022 (Friday) till the completion of 48 hours after the declaration of unaudited financial results of the Company for the quarter and half year ending September 30 2022.It is hereby clarified that the trading window shall be closed after the business hours on September 30 2022 (Friday).
Thu, 29 Sep 2022
Closure of Trading Window
Trading Window for dealing in the equity shares of the Company will remain closed from September 30 2022 (Friday) till the completion of 48 hours after the declaration of unaudited financial results of the Company for the quarter and half year ending 30 September 2022
Tue, 20 Sep 2022
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
Intimation under Securities and Exchange Board of India (SEBI) (Prohibition of Insider Trading) Regulations 2015

Technical Scans View Details >>

Thu, 06 Oct 2022
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 6 Months High Decrease 6 Months
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 953.00 -0.1%
Divi's Laboratories Ltd. 99,171.10 3,738.70 +0.0%
Cipla Ltd. 91,534.16 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 54,354.34 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,831.42 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.78 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.26 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Nureca Ltd.

What is Nureca Ltd. share price?

Can I buy Nureca Ltd. shares now?

What is the Dividend Yield of Nureca Ltd.?

What is the Market Cap of Nureca Ltd.?

What are the key metrics to analyse Nureca Ltd.?

What is the 52 Week High and Low of Nureca Ltd.?

What is the trend of Nureca Ltd. share price?